|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Increased Prevalence of Microthromboses in Retinal Capillaries of Diabetic Individuals
Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
In diabetic retinopathy, capillary nonperfusion and eventual obliteration can lead to retinal ischemia and sight-threatening neovascularization. The occurrence of retinal microthrombosis in human diabetes has long been suspected and occasionally observed but never systematically demonstrated. We used trypsin digestion to isolate the intact vascular network from retinas obtained postmortem from nine diabetic donors (age 64 ± 11 years, duration of diabetes 6 ± 4 years; mean ± SD) and eight age-matched nondiabetic donors. Topographically matched sectors (each one-sixth of retina) of diabetic and nondiabetic retinas were tested sequentially with antibodies to fibrin cross-linking factor XIII and platelet glycoprotein (GP)-IIIa to identify fibrin-platelet thrombi. In some trypsin digests, we also examined vascular cell apoptosis. The retina from a nondiabetic donor, 24 years of age, who had died of trauma, was used to exclude confounding influences caused by the postmortem period. When compared with those of nondiabetic donors, the retinas of diabetic donors showed double the number of capillary segments with colocalized immunostaining for factor XIII and GPIIIa (P = 0.02). The total area of the positive segments was fourfold greater in the diabetic than in the nondiabetic donors (P = 0.02) and correlated with the duration of diabetes (r = 0.71, P < 0.05). Large thrombi were six times more frequent in the diabetic donors (P = 0.03), and there was a significant topographical association of microthrombosis with apoptotic cells in both diabetic and nondiabetic vessels (P = 0.0001). Hence, diabetes of short duration was found to be associated with a greater than normal number and size of platelet-fibrin thrombi in the retinal capillaries. These thrombi can contribute to capillary obliteration and retinal ischemia and may be a practical target for early drug intervention.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Artwohl, K. Muth, K. Kosulin, R. de Martin, T. Holzenbein, G. Rainer, A. Freudenthaler, N. Huttary, L. Schmetterer, W. K. Waldhausl, et al. R-(+)-{alpha}-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/E2F-1 Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E681 - E689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Kern, C. M. Miller, Y. Du, L. Zheng, S. Mohr, S. L. Ball, M. Kim, J. A. Jamison, and D. P. Bingaman Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology Diabetes, February 1, 2007; 56(2): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects Diabetes, December 1, 2005; 54(12): 3418 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kowluru and S. Odenbach Role of Interleukin-1{beta} in the Development of Retinopathy in Rats: Effect of Antioxidants Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4161 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R A Kowluru and S Odenbach Role of interleukin-1{beta} in the pathogenesis of diabetic retinopathy Br. J. Ophthalmol., October 1, 2004; 88(10): 1343 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sugiyama, M. Kobayashi, H. Kawamura, Q. Li, and D. G. Puro Enhancement of P2X7-Induced Pore Formation and Apoptosis: An Early Effect of Diabetes on the Retinal Microvasculature Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 1026 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Kohner Aspirin for diabetic retinopathy BMJ, November 8, 2003; 327(7423): 1060 - 1061. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamashiro, A. Tsujikawa, S. Ishida, T. Usui, Y. Kaji, Y. Honda, Y. Ogura, and A. P. Adamis Platelets Accumulate in the Diabetic Retinal Vasculature Following Endothelial Death and Suppress Blood-Retinal Barrier Breakdown Am. J. Pathol., July 1, 2003; 163(1): 253 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Artwohl, W. F. Graier, M. Roden, M. Bischof, A. Freudenthaler, W. Waldhausl, and S. M. Baumgartner-Parzer Diabetic LDL Triggers Apoptosis in Vascular Endothelial Cells Diabetes, May 1, 2003; 52(5): 1240 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, C. Gerhardinger, and M. Lorenzi Early Complement Activation and Decreased Levels of Glycosylphosphatidylinositol-Anchored Complement Inhibitors in Human and Experimental Diabetic Retinopathy Diabetes, December 1, 2002; 51(12): 3499 - 3504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Romeo, W.-H. Liu, V. Asnaghi, T. S. Kern, and M. Lorenzi Activation of Nuclear Factor-{kappa}B Induced by Diabetes and High Glucose Regulates a Proapoptotic Program in Retinal Pericytes Diabetes, July 1, 2002; 51(7): 2241 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Kern and R. L. Engerman Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin Diabetes, July 1, 2001; 50(7): 1636 - 1642. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |